We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Whitepaper

SARS-CoV-2 Neutralizing Antibody Research and Development

Neutralizing antibodies are currently being investigated as one such strategy against SARS-CoV-2, as they have the potential to block the virus from infecting host cells. Download this whitepaper to learn more about the antiviral mechanism of SARS-CoV-2 neutralizing antibodies and global efforts to develop neutralizing antibody products against the virus.
Whitepaper

COVID-19 Vaccine Discovery and Cold Chain Distribution Requirements

Download this whitepaper to understand more about how automated sample storage can aid in the research of COVID-19.
Whitepaper

Six Key Questions R&D Organizations Struggle To Answer

Life science R&D is developing incredible solutions to global problems. But this ground breaking work is often being done with outdated tools that weren't designed with the complexity of life science in mind. Let's explore the core questions that R&D organizations are struggling to answer.
Whitepaper

Characterizing Formulations, Drug Targets and Viruses With SAXS and WAXS

Access this whitepaper to discover how the analytical techniques that can facilitate research, development and quality control during drug development.
Whitepaper

A Guide to Improving Your R&D Data Maturity

R&D organizations are only as good as their data and the insights their teams can derive from it. This whitepaper highlights the steps you can take to improve the data culture at your company.
Whitepaper

Data Integrity in the Analytical Lab

Assurance of data integrity is increasingly difficult for bioanalytical laboratories. This whitepaper discusses the issues of and procedures for maintaining data integrity.
Whitepaper

Supporting the Pharmaceutical Industry With 21 CFR Part 11 Compliance Readiness

This document describes how Malvern Panalytical systems support system owners, meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.
Whitepaper

The Enduring Success of Hybridoma-based Antibody Development

Download this white paper to learn all about hybridoma-based antibody development, including their key benefits and misconceptions.
Whitepaper

Identify the Next Optimal Clinical Candidate - Faster

Download this white paper to understand how PerkinElmer’s Lead Discovery Premium can help deliver unified, interactive, responsive, data-agnostic access to all users.
Whitepaper

Positioning Your Biobank for Success

This white paper will give you advice on how to save time, money, reduce risk and future-proof your bioband business.
Advertisement